AbbVie, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US00287Y1091
  • NYSE: ABBV
USD
265.21
0.73 (0.28%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Eli Lilly & Co.
Johnson & Johnson
Bristol Myers Squibb Co.
Vertex Pharmaceuticals, Inc.
Zoetis, Inc.
Pfizer Inc.
Regeneron Pharmaceuticals, Inc.
Merck & Co., Inc.
AbbVie, Inc.
Seagen Inc.
Horizon Therapeutics Plc

Why is AbbVie, Inc. ?

1
High Debt company with Weak Long Term Fundamental Strength
  • High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Jun 25
  • INVENTORY TURNOVER RATIO(HY) Lowest at 3.69 times
  • CASH AND EQV(HY) Lowest at USD 11,643 MM
  • INTEREST(Q) Highest at USD 782 MM
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 28.45%, its profits have risen by 16.2% ; the PEG ratio of the company is 1.4
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is AbbVie, Inc. for you?

Low Risk, High Return

Absolute
Risk Adjusted
Volatility
AbbVie, Inc.
19.15%
1.19
26.28%
S&P 500
16.0%
0.70
20.15%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
5.95%
EBIT Growth (5y)
6.49%
EBIT to Interest (avg)
7.46
Debt to EBITDA (avg)
2.38
Net Debt to Equity (avg)
45.57
Sales to Capital Employed (avg)
0.79
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
281.66%
Pledged Shares
0
Institutional Holding
76.07%
ROCE (avg)
25.94%
ROE (avg)
300.50%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
35
Industry P/E
Price to Book Value
-115.40
EV to EBIT
21.91
EV to EBITDA
15.55
EV to Capital Employed
7.46
EV to Sales
7.19
PEG Ratio
NA
Dividend Yield
3.11%
ROCE (Latest)
34.04%
ROE (Latest)
Negative BV
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 19,507 MM

DIVIDEND PER SHARE(HY)

Highest at USD 4.87

INTEREST COVERAGE RATIO(Q)

Highest at 1,092.77

RAW MATERIAL COST(Y)

Fallen by -4.36% (YoY

NET SALES(Q)

Highest at USD 16,990 MM

OPERATING PROFIT(Q)

Highest at USD 8,611 MM

PRE-TAX PROFIT(Q)

Highest at USD 6,080 MM

NET PROFIT(Q)

Highest at USD 5,124.15 MM

EPS(Q)

Highest at USD 2.03

-4What is not working for the Company
ROCE(HY)

Lowest at 0%

DIVIDEND PAYOUT RATIO(Y)

Lowest at 85.08%

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.65 times

Here's what is working for AbbVie, Inc.

Operating Cash Flow
Highest at USD 19,507 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Interest Coverage Ratio
Highest at 1,092.77
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Dividend per share
Highest at USD 4.87 and Grown
In each year in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (USD)

Net Sales
Highest at USD 16,990 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Profit
Highest at USD 8,611 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Pre-Tax Profit
Highest at USD 6,080 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 5,124.15 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Net Profit
At USD 5,124.15 MM has Grown at 59.71%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD 2.03
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost
Fallen by -4.36% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for AbbVie, Inc.

Inventory Turnover Ratio
Lowest at 3.65 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Dividend Payout Ratio
Lowest at 85.08%
in the last five years
MOJO Watch
Company is distributing lower proportion of profits generated as dividend

DPR (%)

Footer loading